Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Élie

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Pharmacological Research|January 12, 2025
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitorRebecca L Brouillette, Christine E Mona, Michael Desgagné, et al.
Annals of Intensive Care|August 22, 2023
Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort studyPiotr Szychowiak, Thierry Boulain, Jean-François Timsit, et al.
Biomolecules|December 8, 2020
Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCRArman A Sadybekov, Rebecca L Brouillette, Egor Marin, et al.
BMC Palliative Care|February 28, 2023
Bicentre, randomized, parallel-arm, sham-controlled trial of transcranial direct-current stimulation (tDCS) in the treatment of palliative care patients with refractory cancer painJean-Paul Nguyen, Hélène Gaillard, Alcira Suarez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2017
A Novel PGM3 Mutation Is Associated With a Severe Phenotype of Bone Marrow Failure, Severe Combined Immunodeficiency, Skeletal Dysplasia, and Congenital MalformationsGuillermo Pacheco-Cuéllar, Julie Gauthier, Valérie Désilets, et al.
Iscience|January 6, 2025
Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized miceJaspreet Jain, Tram N Q Pham, Sharmin Begum, et al.
Data in Brief|July 9, 2020
Data set describing the <i>in vitro</i> biological activity of JMV2009, a novel silylated neurotensin(8-13) analogÉlie Besserer-Offroy, Pascal Tétreault, Rebecca L Brouillette, et al.
Cell Reports|November 28, 2019
Flt3L-Mediated Expansion of Plasmacytoid Dendritic Cells Suppresses HIV Infection in Humanized MiceTram N Q Pham, Oussama Meziane, Mohammad Alam Miah, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
Open Forum Infectious Diseases|December 1, 2025
Social Precariousness and the Outcome of Critical Illnesses in People with HIV: A Multicenter Cohort StudyPiotr Szychowiak, Thierry Boulain, Étienne de Montmollin, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Pharmacological Research|January 12, 2025
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitorRebecca L Brouillette, Christine E Mona, Michael Desgagné, et al.
Annals of Intensive Care|August 22, 2023
Clinical spectrum and prognostic impact of cancer in critically ill patients with HIV: a multicentre cohort studyPiotr Szychowiak, Thierry Boulain, Jean-François Timsit, et al.
Biomolecules|December 8, 2020
Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCRArman A Sadybekov, Rebecca L Brouillette, Egor Marin, et al.
BMC Palliative Care|February 28, 2023
Bicentre, randomized, parallel-arm, sham-controlled trial of transcranial direct-current stimulation (tDCS) in the treatment of palliative care patients with refractory cancer painJean-Paul Nguyen, Hélène Gaillard, Alcira Suarez, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2017
A Novel PGM3 Mutation Is Associated With a Severe Phenotype of Bone Marrow Failure, Severe Combined Immunodeficiency, Skeletal Dysplasia, and Congenital MalformationsGuillermo Pacheco-Cuéllar, Julie Gauthier, Valérie Désilets, et al.
Iscience|January 6, 2025
Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized miceJaspreet Jain, Tram N Q Pham, Sharmin Begum, et al.
Data in Brief|July 9, 2020
Data set describing the <i>in vitro</i> biological activity of JMV2009, a novel silylated neurotensin(8-13) analogÉlie Besserer-Offroy, Pascal Tétreault, Rebecca L Brouillette, et al.
Cell Reports|November 28, 2019
Flt3L-Mediated Expansion of Plasmacytoid Dendritic Cells Suppresses HIV Infection in Humanized MiceTram N Q Pham, Oussama Meziane, Mohammad Alam Miah, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
Open Forum Infectious Diseases|December 1, 2025
Social Precariousness and the Outcome of Critical Illnesses in People with HIV: A Multicenter Cohort StudyPiotr Szychowiak, Thierry Boulain, Étienne de Montmollin, et al.
Pageof 15